Debiopharm is privately-owned Swiss biopharmaceutical company committed to research in Oncology and Infectious diseases to improve patient outcomes and quality of life. Debiopharm International SA aims to develop innovative therapies via our unique “development only” business
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Sartiq is an AI-powered content creation platform for fashion brands . It creates great product images and videos at a fraction of the cost and time of a physical photoshoot. Our enterprise clients publish more than
Agordo, IT If you’ve worn a pair of glasses, we’ve already met. We are a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses. We offer our industry stakeholders in over